NEXEL Stock

NEXEL is a biotechnology research firm that specializes in the advancement of drugs, biotherapeutics, and iPSC technology.

Sign up today and learn more about NEXEL Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About NEXEL Stock

Funding History

January 2019$9.7B
April 2021$17.5B

Management

CEO

Choongseong Han

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo